30
Participants
Start Date
July 31, 2005
Primary Completion Date
September 30, 2011
Study Completion Date
October 31, 2015
Cetuximab
Irinotecan
Cisplatin
Surgery
5-FU
Radiation
NYU Cancer Center, New York
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Eli Lilly and Company
INDUSTRY
NYU Langone Health
OTHER